Colgate-Palmolive (NYSE:CL) Stock Holdings Trimmed by Woodstock Corp

Woodstock Corp lessened its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,545 shares of the company’s stock after selling 320 shares during the period. Woodstock Corp’s holdings in Colgate-Palmolive were worth $2,133,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $25,000. Rise Advisors LLC acquired a new position in Colgate-Palmolive during the 1st quarter worth $38,000. Continuum Advisory LLC grew its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares in the last quarter. Register Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive during the first quarter valued at $48,000. Finally, Gradient Investments LLC raised its stake in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after purchasing an additional 400 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CL shares. Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Citigroup boosted their price target on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Evercore ISI raised their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Finally, UBS Group lifted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $106.00.

View Our Latest Stock Report on CL

Colgate-Palmolive Stock Up 0.9 %

Shares of NYSE:CL opened at $100.10 on Monday. The company has a 50 day moving average of $103.56 and a 200-day moving average of $97.25. Colgate-Palmolive has a one year low of $68.54 and a one year high of $109.30. The stock has a market cap of $82.13 billion, a price-to-earnings ratio of 31.68, a P/E/G ratio of 3.54 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.77 EPS. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.00%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insider Buying and Selling

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares in the company, valued at approximately $529,729.24. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.